You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday.
My phone blew up while I was on vacation last week: The Associated Press Stylebook announced that “health care” should actually be one word, “healthcare.” STAT is still deciding which we should use. Which do you prefer? You can weigh in here.
(Will my newsletters technically be shorter if we switch to “healthcare”? Food for thought.)
Moving Beyond AI Hype in Healthcare
Maybe now we can have a real conversation about AI in health care.
In his recent video, “The People Do Not Yearn for Automation,” The Verge editor-in-chief Nilay Patel critiques the “software brain” mindset—the idea of viewing the world as a series of easily manipulated databases to solve problems. This perspective, he argues, creates a disconnect between the AI world and everyone else.
The AI industry often assumes that AI can solve global challenges, dismissing anti-AI sentiment as a mere marketing issue. However, Patel highlights that those resisting AI adoption raise legitimate concerns about tradeoffs, performance, and real-world impact—concerns that the “software-brained” often overlook.
Continue to STAT+ to read the full story…
Related articles
Dr. Makary's Exit and the Future of Cassidy's Senate Seat: Key Health Policy Shifts
This week’s episode of “The Readout LOUD” is all about health politics. We bring on FDA reporter Lizzy Lawrence to discuss Makary’s departure — why he...
Who Will Lead the FDA Next? The Search for a New Commissioner Heats Up
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to...
Study Links High Air Pollution to Increased Post-Surgical Complications on Utah’s Wasatch Front
New research on Utah’s Wasatch Front—which occasionally experiences the worst air quality in the nation—has found an association between high air poll...
BeOne Secures FDA Approval for Novel Lymphoma Cell Therapy, Advancing Autoimmune Treatment Pipeline
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Biotech’s cell therapy boo...
Why Major Digital Health Companies Are Absent from Medicare’s Chronic Care Pilot Program
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it deli...
Science-Backed: 8,500 Steps Daily for Sustainable Weight Loss
A new study demonstrates that 8,500 daily steps is the sweet spot for weight management. Stewart Cohen/Getty Images Walking 8,500 steps per day can he...
Biogen’s Tau-Targeting Alzheimer’s Drug Shows Promise in Mid-Stage Trial
Biogen reported mixed results Thursday from a mid-stage clinical trial investigating a treatment for Alzheimer’s disease that targets the protein tau...
CREATE Medicines Secures $122M to Advance CAR-T Therapies for Solid Tumors and Autoimmune Diseases
CREATE Medicines has a new name, an expanded pipeline, and now fresh funding to propel the company’s first CAR-T candidates through human trials. Up u...